SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
finance.yahoo.com
12.09.2026 12:48
3 views
Copy link
Save
Pick
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
barrons.com
08.09.2026
Related stories
The price of almost everything on your dinner table is climbing at once — and Wall Street is taking notice
marketwatch.com · 13.09
Iraq’s militias grow bolder in Iran war
ft.com · 13.09
The calculated desperation of Trump-a-palooza
ft.com · 13.09
Russia hits evacuated Kyiv-Warsaw train on line used by foreign leaders
ft.com · 13.09
Why teenagers are doing worse at school
ft.com · 13.09
‘Trumpism’ spawns rare unity at Brics summit
ft.com · 13.09
← Previous
Jim Cramer Discussed The Contradictions Surrounding NVIDIA Corporation (NASDAQ:NVDA)’s Shares
Next →
Jim Cramer Notes lululemon (LULU) is “Executing Really Poorly”